ATI PHARMACOLOGY PROCTORED EXAM 2025/2026 – EXAM-STYLE
QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED ANSWERS | PLUS
RATIONALES | GUARANTEED PASS | 2026/27 LATEST UPDATE | EXAM PREP |
STUDY GUIDE | PRACTICE TEST
SECTION ONE: QUESTIONS 1-50
1. A nurse is preparing to administer a medication that has a high first-pass
effect. The nurse anticipates that this medication will be administered via which
route to achieve the greatest bioavailability?
A. Oral
B. Intravenous
C. Sublingual
D. Transdermal
Correct Answer: B. Intravenous
Rationale: The first-pass effect refers to the extensive metabolism of a drug by the
liver before it reaches systemic circulation. This significantly reduces the
bioavailability of orally administered medications. Intravenous (IV) administration
bypasses the hepatic portal system entirely, delivering 100% of the drug directly
into systemic circulation and therefore avoiding the first-pass effect. While
sublingual and transdermal routes also bypass the first-pass effect, they are subject
to other absorption barriers that make their bioavailability less than 100%, though
still higher than oral. IV administration is the only route that provides complete and
immediate bioavailability by circumventing all absorption and metabolic barriers.**
,2. A client prescribed a beta-blocker for hypertension reports feeling dizzy and
lightheaded upon standing. Which nursing action is most appropriate?
A. Instruct the client to increase fluid intake to 3 liters per day.
B. Administer the medication with a full glass of milk to buffer absorption.
C. Advise the client to rise slowly from a sitting or lying position.
D. Discontinue the medication and notify the healthcare provider immediately.
Correct Answer: C. Advise the client to rise slowly from a sitting or lying
position.
Rationale: The client's symptoms are consistent with orthostatic hypotension, a
common adverse effect of beta-blockers. The most appropriate initial nursing
intervention is to teach the client to change positions slowly to allow the body's
autonomic reflexes time to compensate for the drop in blood pressure. Increasing
fluid intake may be beneficial but is not the immediate, targeted intervention.
Administering with milk does not address the hypotensive effect. Discontinuing the
medication without a provider's order is outside the nurse's scope of practice and
not the first line of action for this manageable side effect.**
3. A healthcare provider prescribes 500 mg of an antibiotic to be administered
intravenously over 60 minutes. The available medication is a 500 mg vial that
must be reconstituted to a concentration of 100 mg/mL. At what rate will the
nurse set the IV infusion pump?
A. 5 mL/hr
B. 50 mL/hr
,C. 100 mL/hr
D. 500 mL/hr
Correct Answer: B. 50 mL/hr
Rationale: First, determine the total volume to be infused: 500 mg / 100 mg/mL =
5 mL. The total volume (5 mL) must be infused over 60 minutes (1 hour). The
infusion rate is therefore 5 mL/hr. A rate of 50 mL/hr would deliver 500 mL over an
hour, which is incorrect as it does not account for the concentration. 100 mL/hr
would deliver 100 mL, and 500 mL/hr would deliver 500 mL, both of which are
inaccurate calculations.**
4. A nurse is monitoring a client receiving a continuous IV infusion of heparin.
Which laboratory value is most critical to monitor to evaluate the therapeutic
effectiveness of the therapy?
A. Prothrombin time (PT)
B. International Normalized Ratio (INR)
C. Activated Partial Thromboplastin Time (aPTT)
D. Platelet count
Correct Answer: C. Activated Partial Thromboplastin Time (aPTT)
Rationale: Heparin exerts its anticoagulant effect by potentiating antithrombin III,
which inactivates thrombin and factor Xa. The aPTT is the standard laboratory test
used to monitor and adjust the dose of unfractionated heparin to maintain a
therapeutic range, typically 1.5 to 2.5 times the control value. PT and INR are used
to monitor the effects of warfarin therapy, not heparin. The platelet count is
, monitored to detect heparin-induced thrombocytopenia (HIT), an adverse effect, but
is not used to measure the therapeutic effectiveness of the drug.**
5. A client asks a nurse why their newly prescribed antidepressant medication
will take several weeks to become effective. What is the most accurate scientific
rationale for this delay?
A. The medication requires time to reach steady-state concentrations in the
blood.
B. The medication must first be metabolized by the liver into its active form.
C. The therapeutic effect is linked to adaptive changes in neurotransmitter
receptors, which occur slowly.
D. The drug's half-life is extremely long, leading to a slow accumulation in fatty
tissues.
Correct Answer: C. The therapeutic effect is linked to adaptive changes in
neurotransmitter receptors, which occur slowly.
Rationale: The delayed onset of therapeutic action for many antidepressants, such
as SSRIs, is not primarily due to pharmacokinetic factors like achieving steady state,
which occurs within a few days. Instead, it is due to pharmacodynamic changes; the
clinical improvement is associated with downstream neuroadaptive processes,
including the down-regulation and desensitization of serotonin receptors, which
take several weeks to develop. While drug metabolism and accumulation play roles
in overall drug action, they do not account for the specific 2-4 week delay
characteristic of antidepressant therapy.**
QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED ANSWERS | PLUS
RATIONALES | GUARANTEED PASS | 2026/27 LATEST UPDATE | EXAM PREP |
STUDY GUIDE | PRACTICE TEST
SECTION ONE: QUESTIONS 1-50
1. A nurse is preparing to administer a medication that has a high first-pass
effect. The nurse anticipates that this medication will be administered via which
route to achieve the greatest bioavailability?
A. Oral
B. Intravenous
C. Sublingual
D. Transdermal
Correct Answer: B. Intravenous
Rationale: The first-pass effect refers to the extensive metabolism of a drug by the
liver before it reaches systemic circulation. This significantly reduces the
bioavailability of orally administered medications. Intravenous (IV) administration
bypasses the hepatic portal system entirely, delivering 100% of the drug directly
into systemic circulation and therefore avoiding the first-pass effect. While
sublingual and transdermal routes also bypass the first-pass effect, they are subject
to other absorption barriers that make their bioavailability less than 100%, though
still higher than oral. IV administration is the only route that provides complete and
immediate bioavailability by circumventing all absorption and metabolic barriers.**
,2. A client prescribed a beta-blocker for hypertension reports feeling dizzy and
lightheaded upon standing. Which nursing action is most appropriate?
A. Instruct the client to increase fluid intake to 3 liters per day.
B. Administer the medication with a full glass of milk to buffer absorption.
C. Advise the client to rise slowly from a sitting or lying position.
D. Discontinue the medication and notify the healthcare provider immediately.
Correct Answer: C. Advise the client to rise slowly from a sitting or lying
position.
Rationale: The client's symptoms are consistent with orthostatic hypotension, a
common adverse effect of beta-blockers. The most appropriate initial nursing
intervention is to teach the client to change positions slowly to allow the body's
autonomic reflexes time to compensate for the drop in blood pressure. Increasing
fluid intake may be beneficial but is not the immediate, targeted intervention.
Administering with milk does not address the hypotensive effect. Discontinuing the
medication without a provider's order is outside the nurse's scope of practice and
not the first line of action for this manageable side effect.**
3. A healthcare provider prescribes 500 mg of an antibiotic to be administered
intravenously over 60 minutes. The available medication is a 500 mg vial that
must be reconstituted to a concentration of 100 mg/mL. At what rate will the
nurse set the IV infusion pump?
A. 5 mL/hr
B. 50 mL/hr
,C. 100 mL/hr
D. 500 mL/hr
Correct Answer: B. 50 mL/hr
Rationale: First, determine the total volume to be infused: 500 mg / 100 mg/mL =
5 mL. The total volume (5 mL) must be infused over 60 minutes (1 hour). The
infusion rate is therefore 5 mL/hr. A rate of 50 mL/hr would deliver 500 mL over an
hour, which is incorrect as it does not account for the concentration. 100 mL/hr
would deliver 100 mL, and 500 mL/hr would deliver 500 mL, both of which are
inaccurate calculations.**
4. A nurse is monitoring a client receiving a continuous IV infusion of heparin.
Which laboratory value is most critical to monitor to evaluate the therapeutic
effectiveness of the therapy?
A. Prothrombin time (PT)
B. International Normalized Ratio (INR)
C. Activated Partial Thromboplastin Time (aPTT)
D. Platelet count
Correct Answer: C. Activated Partial Thromboplastin Time (aPTT)
Rationale: Heparin exerts its anticoagulant effect by potentiating antithrombin III,
which inactivates thrombin and factor Xa. The aPTT is the standard laboratory test
used to monitor and adjust the dose of unfractionated heparin to maintain a
therapeutic range, typically 1.5 to 2.5 times the control value. PT and INR are used
to monitor the effects of warfarin therapy, not heparin. The platelet count is
, monitored to detect heparin-induced thrombocytopenia (HIT), an adverse effect, but
is not used to measure the therapeutic effectiveness of the drug.**
5. A client asks a nurse why their newly prescribed antidepressant medication
will take several weeks to become effective. What is the most accurate scientific
rationale for this delay?
A. The medication requires time to reach steady-state concentrations in the
blood.
B. The medication must first be metabolized by the liver into its active form.
C. The therapeutic effect is linked to adaptive changes in neurotransmitter
receptors, which occur slowly.
D. The drug's half-life is extremely long, leading to a slow accumulation in fatty
tissues.
Correct Answer: C. The therapeutic effect is linked to adaptive changes in
neurotransmitter receptors, which occur slowly.
Rationale: The delayed onset of therapeutic action for many antidepressants, such
as SSRIs, is not primarily due to pharmacokinetic factors like achieving steady state,
which occurs within a few days. Instead, it is due to pharmacodynamic changes; the
clinical improvement is associated with downstream neuroadaptive processes,
including the down-regulation and desensitization of serotonin receptors, which
take several weeks to develop. While drug metabolism and accumulation play roles
in overall drug action, they do not account for the specific 2-4 week delay
characteristic of antidepressant therapy.**
